CXCL8 and hepatocellular carcinoma: Our preliminary data revealed that exclusion of HCC among PNALT patients could be predicted when both sTNFR-II and IL-8 are assessed together at a cutoff value ≥ 389 pg/ml and IL-8 < 290 pg/ml, respectively.